News Releases

Date Title and Summary Additional Formats
Toggle Summary HTG Molecular Announces Extension to Precision Diagnostic Partnership (PDP) Program Three for Companion Diagnostic Submission
TUCSON, Ariz. , Sept. 27, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (“HTG”), a provider of instruments, reagents, and services for molecular profiling applications, today announced that it has entered into an amendment to the third statement of work (“SOW Three”)
View HTML
Toggle Summary HTG Molecular to Present a Corporate Overview at the Cantor Fitzgerald Global Healthcare Conference
TUCSON, Ariz. , Sept. 26, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a provider of instruments, reagents, and services for molecular profiling applications, today announced that TJ Johnson, Chief Executive Officer, will present a corporate overview at the Cantor
View HTML
Toggle Summary HTG Molecular to Present a Corporate Overview at the H.C. Wainwright 20th Annual Global Investment Conference
TUCSON, Ariz. , Aug. 30, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a provider of instruments, reagents, and services for molecular profiling applications, today announced that TJ Johnson, Chief Executive Officer, will present a corporate overview at the H.C.
View HTML
Toggle Summary HTG Introduces the HTG EdgeSeq Mouse miRNA Whole Transcriptome Assay, a Comprehensive Panel for miRNA Expression Analysis for use in Translational Medicine and Preclinical Studies
TUCSON, Ariz. , Aug. 29, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a provider of instruments, reagents, and services for molecular profiling applications, today announced the pre-launch introduction of the new HTG EdgeSeq Mouse miRNA Whole Transcriptome Assay
View HTML
Toggle Summary HTG Molecular Announces 2nd Amendment to Second Statement of Work with QIAGEN Manchester Limited
TUCSON, Ariz. , Aug. 20, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a provider of instruments, reagents, and services for molecular profiling applications, today announced that it has entered into a second amendment to the second statement of work (“SOW Two”)
View HTML
Toggle Summary HTG Molecular Appoints Michelle R. Griffin to its Board of Directors
TUCSON, Ariz. , Aug. 16, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a provider of instruments, reagents, and services for molecular profiling applications, today announced the appointment of Ms. Michelle Griffin to its Board of Directors.  “We are pleased to
View HTML
Toggle Summary HTG Molecular Diagnostics Fulfills First Orders for its Next-Generation Sequencing-Based HTG EdgeSeq Precision Immuno-Oncology Panel
TUCSON, Ariz. , Aug. 15, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a provider of instruments, reagents, and services for molecular profiling applications, today announced it launched its HTG EdgeSeq Precision Immuno-Oncology Panel and has delivered its first
View HTML
Toggle Summary HTG Molecular Announces Amendment to Second Statement of Work with QIAGEN Manchester Limited
TUCSON, Ariz. , Aug. 09, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc.  (Nasdaq: HTGM) (HTG), a provider of instruments, reagents, and services for molecular profiling applications, today announced that it has entered into an amendment to the second statement of work (“SOW Two”) under
View HTML
Toggle Summary HTG Molecular Diagnostics Reports Second Quarter 2018 Results
Revenue increased 179% and 190%, respectively, compared to the three and six-month periods in the prior year                Call scheduled for today, August 7 , at 4:30 pm ET TUCSON, Ariz. , Aug. 07, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc.
View HTML
Toggle Summary HTG Molecular Diagnostics and Oncologie, Inc. Complete Master Agreement to Partner on Biomarker Development for Immuno-oncology Drug Development
TUCSON, Ariz. , Aug. 03, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a provider of instruments, reagents, and services for molecular profiling applications and Oncologie, Inc. an innovative biotechnology company with operations in Boston and Shanghai , today
View HTML